This study is looking at how useful genomic sequencing (GS) is for pregnant individuals. If you are pregnant with a fetus that appears structurally normal and are already planning to have prenatal diagnostic testing like chorionic villus sampling or amniocentesis with a standard chromosomal microarray, you might be able to join. The study offers GS as an additional test to look for specific genetic conditions that could affect your baby's health. The main goal is to see how often GS finds genetic changes that are known to cause disease. You must be between 18 and 64 years old to participate. The study aims to enroll 1000 participants, but its current recruitment status is unclear.

Study design

This is an interventional study that plans to enroll 1000 participants. It is not specified if it is randomized or blinded.

What's involved

You would undergo prenatal diagnostic testing (chorionic villus sampling or amniocentesis) and have genomic sequencing performed. Blood or saliva samples will also be collected from both parents.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, detection of pathogenic or likely pathogenic variants, is measured up to 2 months after enrollment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.